Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AMICON ULTRAFILTRATION MEMBRANES CMII

K-Number: K810810 · 1981-04-17

ApplicantAmicon, Inc.
Decision Date1981-04-17
Product CodeDHX
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

AMICON ULTRAFILTRATION MEMBRANES CMII is the device name listed in this FDA 510(k) record. The listed applicant is Amicon, Inc.. It received FDA 510(k) clearance on 1981-04-17 under 510(k) number K810810. The device is classified under product code DHX. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AMICON ULTRAFILTRATION MEMBRANES CMII?

AMICON ULTRAFILTRATION MEMBRANES CMII is a medical device that received FDA 510(k) clearance on 1981-04-17. The listed applicant is Amicon, Inc.. The 510(k) number is K810810.

When did AMICON ULTRAFILTRATION MEMBRANES CMII receive FDA 510(k) clearance?

AMICON ULTRAFILTRATION MEMBRANES CMII received FDA 510(k) clearance on 1981-04-17, under 510(k) number K810810.

Who is the listed applicant for AMICON ULTRAFILTRATION MEMBRANES CMII?

The FDA 510(k) record lists Amicon, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AMICON ULTRAFILTRATION MEMBRANES CMII?

The FDA product code for AMICON ULTRAFILTRATION MEMBRANES CMII is DHX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Amicon, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K930168CENTRICON -50 CONCENTRATORK902837AMICON DIAFILTER 30 HEMOCONCENTRATORK901286AMICON HEMOCONCENTRATOR SETK900280CENTRIPREP 100K895405AMICON MINIFILTER PLUS HEMOFILTERK893733CENTRICON CONCENTRATOR

View all 20 devices →

Related Devices (Code: DHX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K223921Access CEABeckman Coulter, Inc.K231517VITROS Immunodiagnostic Products CEA Reagent PackOrtho Clinical DiagnosticsK200215ADVIA Centaur CEA AssaySiemens Healthcare Disgnostics, Inc.K081615OLYMPUS CEA - CARCINOEMBRYONIC ANTIGENOlympus America, Inc.K080194VIDAS CEA (S) ASSAYbioMerieux, Inc.K071603DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)Dade Behring, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑